Lanzhen Liu

Title: Lanzhen Liu: Innovator in Pyrimidine-Fused Cyclic Compounds

Introduction

Lanzhen Liu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine-fused cyclic compounds. His research focuses on the preparation methods and applications of these compounds in treating diseases associated with abnormal SHP2 activity.

Latest Patents

Lanzhen Liu holds a patent for a pyrimidine-fused cyclic compound, which includes a preparation method and its applications. The patent details a compound or its pharmaceutically acceptable variants, including salts, hydrates, prodrugs, stereoisomers, solvates, or isotope-labeled compounds. This invention is aimed at developing a medicament for the prevention and treatment of conditions linked to abnormal SHP2 activity.

Career Highlights

Throughout his career, Lanzhen Liu has worked with prominent companies in the biopharmaceutical sector. He has been associated with Blueray Therapeutics (Shanghai) Co., Ltd and Shanghai Blueray Biopharma Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Lanzhen Liu has collaborated with notable professionals in his field, including Bin Zou and Xianlei Fu. These collaborations have fostered innovation and enhanced the research outcomes in the development of new medicinal compounds.

Conclusion

Lanzhen Liu's contributions to the field of medicinal chemistry, particularly through his patent on pyrimidine-fused cyclic compounds, highlight his role as an innovator. His work continues to pave the way for advancements in the treatment of diseases associated with SHP2 activity.